International Business News - CEPH http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc. and marketed by Cephalon Inc. http://www.ibtimes.com/articles/20080812/fda-warns-of-skin-reactions-with-alcoholism-drug.htm Tue, 12 Aug 2008 17:29:22 EDT Biotech drugmaker Cephalon spent nearly $516,000 lobbying the federal government in the second quarter, according to a recent disclosure form. The Frazer, Pa.-based company lobbied on a range of bills affecting the development, sales and marketing of prescription drugs, according to a form filed July 21 with the House clerk's office. http://www.ibtimes.com/articles/20080812/cephalon-spent-nearly-516k-lobbying-govt-in-2q.htm Tue, 12 Aug 2008 09:59:56 EDT Among the earnings projection stories for Tuesday, July 29, from AP Financial News: FRAZER, Pa. (AP)--Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full fiscal year after posting second-quarter profit results that beat Wall Street expectations. http://www.ibtimes.com/articles/20080729/outlook-roundup-cephalon-electronic-arts.htm Tue, 29 Jul 2008 18:07:35 EDT Biotechnology company Cephalon Inc. on Tuesday raised its outlook for the full fiscal year after posting second-quarter profit results that beat Wall Street expectations. http://www.ibtimes.com/articles/20080729/cephalon-raises-full-year-guidance-on-strong-2q.htm Tue, 29 Jul 2008 17:32:50 EDT Biotechnology company Cephalon Inc. said Tuesday it swung to a profit in the second quarter, helped by brisk sales of central nervous system drugs and of new drugs it didn't offer last year. http://www.ibtimes.com/articles/20080729/cephalon-swings-to-2q-profit.htm Tue, 29 Jul 2008 17:27:12 EDT Among the earnings stories for Tuesday, July 29, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080729/earnings-roundup-valero-sonic-auto.htm Tue, 29 Jul 2008 17:56:29 EDT AutoGenomics Inc., which makes diagnostic systems that test for genetic and infectious diseases and cancer, is planning an initial public offering of common stock, according to a Securities and Exchange Commission filing on Friday. http://www.ibtimes.com/articles/20080725/diagnostic-test-maker-autogenomics-plans-ipo.htm Fri, 25 Jul 2008 12:28:44 EDT Drug developer Barr Pharmaceuticals Inc. said Thursday it is challenging Cephalon Inc.'s patent on the pain drug Fentora and in turn is being sued to prevent it from marketing a generic version. http://www.ibtimes.com/articles/20080724/barr-challenges-cephalon-pain-drug-patent.htm Thu, 24 Jul 2008 16:18:08 EDT Shares of biotechnology company Biogen Idec Inc. jumped Tuesday after its partner on the blockbuster drug Rituxan reported a surge in second-quarter sales. http://www.ibtimes.com/articles/20080715/biogen-idec-shares-rise-on-2q-rituxan-sales.htm Tue, 15 Jul 2008 19:41:33 EDT Biotechnology company Cephalon Inc. said Tuesday its leukemia drug Treanda, in combination with Genentech Inc.'s Rituxan, prompted a response in non-Hodgkin's lymphoma patients during a midstage study. http://www.ibtimes.com/articles/20080715/cephalon-drug-prompts-response-in-cancer-study.htm Tue, 15 Jul 2008 10:18:16 EDT Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesday. http://www.ibtimes.com/articles/20080624/sector-snap-biotech-_-large-cap-or-small-cap.htm Tue, 24 Jun 2008 12:51:24 EDT The Nasdaq 100 index dropped sharply Friday with high oil prices weighing on shares of UAL Corp., which operates United Airlines. UAL declined 95 cents, or 11.7 percent, to $7.16. On Thursday, United said it will work with Continental Airlines Inc. in an alliance to help offset rising fuel costs. http://www.ibtimes.com/articles/20080620/nasdaq-100-leaders-and-laggards-uaua-apol.htm Fri, 20 Jun 2008 17:20:29 EDT Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday. http://www.ibtimes.com/articles/20080620/analysts-see-higher-drug-sales-for-cephalon.htm Fri, 20 Jun 2008 12:18:01 EDT Government regulators said Thursday they are preparing to allow highly addictive medications, including powerful painkillers, to be prescribed online, a goal long-sought by health insurers and large employers. http://www.ibtimes.com/articles/20080619/doctors-may-soon-prescribe-addictive-drugs-online.htm Thu, 19 Jun 2008 18:14:43 EDT The Nasdaq 100 sank Friday after the Labor Department said unemployment jumped last month to levels not seen in 22 years, and crude oil soared to a new record just under $140 a barrel. http://www.ibtimes.com/articles/20080606/nasdaq-100-leaders-and-laggards-fmcn-yhoo.htm Fri, 06 Jun 2008 16:36:44 EDT The Nasdaq 100 tumbled in midday trading Friday after the Labor Department said unemployment jumped last month to levels not seen in 22 years, and crude oil prices resumed their upward charge. http://www.ibtimes.com/articles/20080606/midday-leaders-and-laggards-nasdaq-100.htm Fri, 06 Jun 2008 12:18:53 EDT Shares of drug developer Incyte Corp. fell Tuesday after several analysts said that a drug candidate to treat a bone marrow disease has only shown efficacy in treating symptoms of the disease, not the disease itself. http://www.ibtimes.com/articles/20080603/incyte-shares-fall-on-bone-marrow-drug-concerns.htm Tue, 03 Jun 2008 18:47:50 EDT Cephalon Inc.'s launch of cancer drug Treanda won't hurt sales of rival drug Rituxan, a JP Morgan analyst said Tuesday. Treanda is approved to treat chronic lymphocytic leukemia, a slowly progressing cancer that affects the blood and bone marrow. It also is being studied as possible treatment for non-Hodgkin's lymphoma, which would put it in direct competition with Rituxan, made by Genentech Inc. and Biogen Idec Inc. http://www.ibtimes.com/articles/20080527/sector-wrap-cancer-drug-developers.htm Tue, 27 May 2008 15:50:27 EDT As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs who have secured lucrative research and development partnerships. http://www.ibtimes.com/articles/20080521/partnerships-drive-big-stock-gains-for-small-biotechs.htm Wed, 21 May 2008 16:58:51 EDT Pharmaceutical companies eager to keep less expensive alternatives to their drugs off the market are increasingly reaching legal agreements with generic drugmakers to accomplish that goal, a government agency said Wednesday. http://www.ibtimes.com/articles/20080521/ftc-legal-settlements-delay-cheaper-drugs.htm Wed, 21 May 2008 17:49:16 EDT